Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Day-to-day measurement of physical activity and risk of atrial fibrillation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Driving following defibrillator implantation: a nationwide register-linked survey study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Self-reported and genetically predicted coffee consumption and smoking in dementia: A Mendelian randomization study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk and impact of chronic cough in obese individuals from the general population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Epigenetic regulation of F2RL3 associates with myocardial infarction and latelet function

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Chronic lymphocytic leukaemia clones are detectable decades before diagnosis

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • Henry N Ginsberg
  • Chris J Packard
  • M John Chapman
  • Jan Borén
  • Carlos A Aguilar-Salinas
  • Maurizio Averna
  • Brian A Ference
  • Daniel Gaudet
  • Robert A Hegele
  • Sander Kersten
  • Gary F Lewis
  • Alice H Lichtenstein
  • Philippe Moulin
  • Børge G Nordestgaard
  • Alan T Remaley
  • Bart Staels
  • Erik S G Stroes
  • Marja-Riitta Taskinen
  • Lale S Tokgözoğlu
  • Anne Tybjaerg-Hansen
  • Jane K Stock
  • Alberico L Catapano
Vis graf over relationer

Recent advances in human genetics, together with a large body of epidemiologic, preclinical, and clinical trial results, provide strong support for a causal association between triglycerides (TG), TG-rich lipoproteins (TRL), and TRL remnants, and increased risk of myocardial infarction, ischaemic stroke, and aortic valve stenosis. These data also indicate that TRL and their remnants may contribute significantly to residual cardiovascular risk in patients on optimized low-density lipoprotein (LDL)-lowering therapy. This statement critically appraises current understanding of the structure, function, and metabolism of TRL, and their pathophysiological role in atherosclerotic cardiovascular disease (ASCVD). Key points are (i) a working definition of normo- and hypertriglyceridaemic states and their relation to risk of ASCVD, (ii) a conceptual framework for the generation of remnants due to dysregulation of TRL production, lipolysis, and remodelling, as well as clearance of remnant lipoproteins from the circulation, (iii) the pleiotropic proatherogenic actions of TRL and remnants at the arterial wall, (iv) challenges in defining, quantitating, and assessing the atherogenic properties of remnant particles, and (v) exploration of the relative atherogenicity of TRL and remnants compared to LDL. Assessment of these issues provides a foundation for evaluating approaches to effectively reduce levels of TRL and remnants by targeting either production, lipolysis, or hepatic clearance, or a combination of these mechanisms. This consensus statement updates current understanding in an integrated manner, thereby providing a platform for new therapeutic paradigms targeting TRL and their remnants, with the aim of reducing the risk of ASCVD.

TidsskriftEuropean Heart Journal
Udgave nummer47
Sider (fra-til)4791-4806
Antal sider16
StatusUdgivet - 14 dec. 2021

Bibliografisk note

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

ID: 69975682